Construction and Evaluation of the Tumor-Targeting, Cell-Penetrating Multifunctional Molecular Probe iCREKA

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/cmmi/volume-2018/7929617/figures/7929617.fig.008a.svgz" name="7929617.fig.008a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>1 h after injection</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/cmmi/volume-2018/7929617/figures/7929617.fig.008b.svgz" name="7929617.fig.008b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>3 h after injection</td></tr></table>

<div>Fluorescence distribution in tumor tissues at 1 h (a) and 3 h (b) after tail-vein injection of FITC-iCREKA (A) and FITC-CREKA (A1) into model mice bearing U87 gliomas. (A) FITC-iCREKA; (A1) FITC-CREKA; (B) and (B1) merged images showing FITC-iCREKA/FITC-CREKA and the nucleus. Magnification: ×200.</div>

Contrast Media & Molecular Imaging

fig8

Figure 8

Figure 8: Construction and Evaluation of the Tumor-Targeting, Cell-Penetrating Multifunctional Molecular Probe iCREKA 